• 25 Organisations —
  • Cancer Vaccine Industry Q3 2022- by Antigen Type
1. AIVITA Biomedical 2016
2. AVAX Technologies 1990
3. Boehringer Ingelheim 1885
4. Brenus Pharma 2014
5. BriaCell Therapeutics 2004
6. Corixa 1994
7. Defence Therapeutics
8. Elios Therapeutics
9. Enochian BioSciences 2011
10. EpiThany 2014
11. Heat Biologics 2008
12. Hookipa Biotech 2011
13. Imvax 2015
14. MaxiVAX 2005
15. NEUVOGEN
16. NewLink Genetics 1999
17. Northwest Biotherapeutics 1998
18. NovaRx 1997
19. Onyvax 1997
20. PDC*line Pharma 2014
21. Photonpharma 2018
22. Polynoma 2007
23. Southwest Oncology Group 1956
24. Vaccinogen 2007
25. Vectorite Biotech

«Cancer Vaccine Industry Q3 2022- by Antigen Type»

  • — organisation
  • — hubs and other organisation types

Industries

AI R&D Pharma (DPI)
Dendritic Cells
Dendritic Cells, Private
Dendritic Cells, Public
FemTech
Private, Tumor-Specific Antigens, Whole-Cell Antigens
Reproductive Health & Contraception
Tumor-Associated Antigens, Whole-Cell Antigens
Whole-Cell Antigens

test_custom_domain_2
© 2026